Accessibility Menu
 
Nexalin Technology logo

Nexalin Technology

(NASDAQ) NXL

Current Price$0.42
Market Cap$7.37M
Since IPO (2022)-82%
5 YearN/A
1 Year-84%
1 Month-1%

Nexalin Technology Financials at a Glance

Market Cap

$7.37M

Revenue (TTM)

$156.93K

Net Income (TTM)

$8.68M

EPS (TTM)

$-0.59

P/E Ratio

-0.67

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Price

$0.42

Volume

15,414

Open

$0.39

Previous Close

$0.42

Daily Range

$0.38 - $0.42

52-Week Range

$0.36 - $2.57

NXL News

No articles available.

NXL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nexalin Technology

Industry

Healthcare Equipment and Supplies

Employees

6

CEO

Mark White

Headquarters

Houston, TX 77056, US

NXL Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-56%

Net Income Margin

-55%

Return on Equity

-178%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-1.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.37M

Shares Outstanding

18.65M

Volume

15.41K

Short Interest

0.00%

Avg. Volume

337.34K

Financials (TTM)

Gross Profit

$132.13K

Operating Income

$7.75M

EBITDA

$7.74M

Operating Cash Flow

$3.94M

Capital Expenditure

$0.00

Free Cash Flow

$3.94M

Cash & ST Invst.

$3.48M

Total Debt

$0.00

Nexalin Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$18.15K

-49.6%

Gross Profit

$436.62K

-1970.9%

Gross Margin

-24.06%

N/A

Market Cap

$7.37M

N/A

Market Cap/Employee

$1.23M

N/A

Employees

6

N/A

Net Income

$2.28M

+7.0%

EBITDA

$2.27M

+9.3%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$4.35M

-5.2%

Accounts Receivable

$7.92K

-47.8%

Inventory

$160.22K

+1.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.69%

N/A

Return on Invested Capital

-1.86%

N/A

Free Cash Flow

$1.47M

-117.8%

Operating Cash Flow

$1.47M

-83.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CLGNCollPlant Biotechnologies Ltd.
$0.61+0.82%
RBOTVicarious Surgical Inc.
$1.04+2.97%
MODDModular Medical, Inc.
$0.18-4.63%
IINNInspira Technologies Oxy B.H.N. Ltd.
$0.55-2.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.53-0.33%
NVDANvidia
$172.70-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%

Questions About NXL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.